Name: Jack James
Alcami Site: Wilmington, NC

How long have you been with Alcami?
I have been with the company for 21 years.

What is your role? 
I am a formulations scientist, primarily focused on oral solid dosage forms.

What is the most rewarding part of your job?
Potentially improving someone’s life through solving formulations problems that enable a drug to move from Alcami development labs to our integrated manufacturing suites.

Alcami will be presenting and exhibiting at PharmaTalk 2018 to be held June 5-6 2018 in Berlin, Germany. Be sure to visit us at our booth to connect with the Alcami team.

Presentation

Serialisation – Approach to Implementation and Execution

You're invited to attend an open house at our Wilmington, North Carolina site.

Join us for an in-depth look at our industry-leading capabilities and service offerings, as well as behind the scenes tours of our laboratories, packaging and stability facilities, and oral solid dose formulation and manufacturing suites.

The second edition of the Beyond the Bench series features three of Alcami’s longest tenured employees. Meg, Karen, and Sally have worked at Alcami and its legacy companies over a century, collectively. These women share in common not only a long history with the company, but they are all also great at sharing their knowledge. Please meet Meg, Karen, and Sally. 

Alcami applauds your loyalty and dedication. You are all valued, expert contributors at your sites! Please introduce yourselves and paint a picture of your start with the company .

Alcami will be exhibiting at BIO International Convention in Boston, MA, June 4 - 7, 2018. 

Be sure to stop by Booth 267 to speak with our team!  

At Alcami, the health and safety of our workers is not taken lightly. Rooted in the foundation of The Alcami Way, safety comes first and is one of our non-negotiables. As a trusted partner and supplier, we can help you achieve your product stewardship and sustainability goals by providing a safe and healthy working environment for our employees.

The globalization of the pharmaceutical industry has led to supply chains that can be extremely complex and difficult to manage. In some cases, the health and safety practices can be vastly different than the current expectations from the public and shareholders. As sustainability intelligence increases, transformative operational strategies are needed to optimize your supply chains and meet your goals.

Durham, NC (USA) – May 3, 2018 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of commendation, recognizing the company’s operational excellence, celebrating its industry-leading accomplishments, and applauding the organization for improving St. Louis citizens’ quality of life.

State Representative Steven Roberts of St. Louis District 77 and City of St. Louis Chief Technology Officer Robert Gaskill-Clemons will issue the proclamation and congratulatory letter Tuesday, May 8, 2018, 2:00 p.m., at an invitation-only customer open house event inside Alcami’s state-of-the-art Center of Excellence for analytical testing.

According to the Food and Drug Administration and the Orphan Drug Designation program,  orphan status is applicable to drugs and biologics which are defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug.” Due to the high costs and low demands of the drug product, it is important to efficiently use your API supply during the formulation process. This case study presents how Alcami successfully helped a client overcome an API supply shortage using Quality by Design studies to successfully formulate an orphan drug product.